Slingshot members are tracking this event:
Three more Phase 3 clinical trials of ABT-494 will begin enrollment in early 2016 and will include patients with an inadequate response to biologics and patients who are MTX-naive
Slingshot Insights Explained
Feb 19, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Clinical Trials, Abt-494, Mtx-naive